SpyBiotech

 

  Follow

Location: United Kingdom

Founded in 2017

Privately Held


Develops innovative techniques to create vaccines by utilizing cutting-edge technology and research for improved immunization solutions.
"SpyBiotech is a spin-out from the University of Oxford pioneering a powerful new approach to generate vaccines. SpyBiotech have developed unique technology to transform how vaccines are created. Features: Unique access to protein superglue for vaccines: SpyTag/SpyCatcher; Rapid and irreversible linkage of antigen to virus-like particle platform; Specific assembly to give an optimal focused immune response; Applicable to a wide range of infectious diseases (viral, bacterial, parasitic) and potentially to cancer."
Description Source: VentureRadar Research / Company Website

Updates


UK Life Sciences Future50 (2023)
Award
02 Dec 2023
One of the "Future50" companies
Source: pwc.co.uk
UK Life Sciences Future50 (2023)
Research Report
02 Dec 2023
One of the "Future50" companies
Source: pwc.co.uk
Bio€quity Europe 2023 - Presenting Companies
Conference
14 May 2023
One of Presenting Companies
Website Traffic Trend
Business Insight
01 Sep 2021
Website traffic has increased in the past 3 months, up from a ranking of 664,826 to 398,047.
Source:
Venture-funding News
Equity Funding
10 Feb 2021
SpyBiotech Raises $32.5M in Series A Funding
Source: finsmes.com
Website Traffic Trend
Business Insight
01 Mar 2019
Website traffic has increased in the past 3 months, up from a ranking of 656,038 to 457,335.
Source:
Disrupt 100 (2018)
Award
01 May 2018
Ranked #82 (of 100)
Venture-funding News
Equity Funding
31 Mar 2017
Oxford startup SpyBiotech raises £4m Seed
Source: uktech.news

Funding Signals


VENTURE FUNDED

SPIN-OFF

Spinouts UKVentureRadar Research / Company Website
Export Similar Companies

Similar Companies


Company Country Status Description
VaccitechUnited KingdomPublicly Traded
Vaccitech is a spin-out company from the University of Oxford’s Jenner Institute, one of the oldest and most renowned vaccine research centres in the world. We develop leading T...
GEOVAX, INC.USAPublicly Traded
GeoVax is developing the next generation of vaccines and immunotherapies to address unmet medical needs in cancer and infectious disease. Our current development programs are...
Celestial TherapeuticsUSAPrivately Held
Celestial Therapeutics Inc. is a new California biotech developing novel proteins for treatment of infectious diseases and inflammatory conditions. Focus is new drugs for treating...
20Med TherapeuticsNetherlandsPrivately Held
20Med Therapeutics is a Dutch biotechnology company focused on the development of prophylactic and therapeutic vaccines. Based on its proprietary bioresponsive polymer...
Delonix BioworksChinaPrivately Held
Delonix Bioworks is working on synthetic biology approaches to develop the next generation medical solutions for infectious diseases and cancer; current lead programs target...
VirometixSwitzerlandPrivately Held
Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and...
Show all
VentureRadar Score

Is this your company?

Claim this profile and
update details for free
Sub-Scores
Social Proof
980
Website Traffic
798
Auto Analyst Score
680
Popularity on VentureRadar
989
Website Popularity
Low Traffic Sites
Low
High Traffic Sites
High
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Open PageRank: 2,016,451 | spybiotech.com
Auto Analyst Score
68
Auto Analyst Score: 68 | spybiotech.com
VentureRadar Popularity
High
VentureRadar Popularity: High
The popularity score combines profile views, clicks and the number of times the company appears in search results.

Free Sign-up for VentureRadar access

or






By continuing, you agree to VentureRadar's Terms of Service, Privacy Policy and Cookie Policy.

To continue, please confirm you are not a robot